0.776
price down icon1.80%   -0.0142
after-market Dopo l'orario di chiusura: .77 -0.006 -0.77%
loading

Omega Therapeutics Inc Borsa (OMGA) Ultime notizie

pulisher
Nov 20, 2024

Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer – Company Announcement - Financial Times

Nov 20, 2024
pulisher
Nov 19, 2024

Piper Sandler Lowers Omega Therapeutics (NASDAQ:OMGA) Price Target to $4.00 - Defense World

Nov 19, 2024
pulisher
Nov 18, 2024

Omega Therapeutics Reports Third Quarter 2024 Results - TipRanks

Nov 18, 2024
pulisher
Nov 17, 2024

Omega Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

Omega Therapeutics stock target cut, keeps Overweight on clinical updates By Investing.com - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

Shares of Flagship-founded biotech fall as CEO departs - The Business Journals

Nov 15, 2024
pulisher
Nov 15, 2024

Omega Therapeutics (NASDAQ:OMGA) Downgraded to Market Perform Rating by Raymond James - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Piper Sandler Issues Pessimistic Forecast for Omega Therapeutics (NASDAQ:OMGA) Stock Price - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Omega Therapeutics Inc (OMGA) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Omega Therapeutics Names Kaan Certel as CEO - MarketWatch

Nov 14, 2024
pulisher
Nov 14, 2024

Omega Therapeutics Announces Successful Completion of Phase - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Omega Therapeutics, Inc. Announces Chief Executive Officer Changes - Marketscreener.com

Nov 14, 2024
pulisher
Nov 13, 2024

Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner - Financial Times

Nov 13, 2024
pulisher
Nov 08, 2024

Omega Therapeutics (NASDAQ:OMGA) Stock Price Down 0.9%Should You Sell? - MarketBeat

Nov 08, 2024
pulisher
Nov 01, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Nov 01, 2024
pulisher
Oct 29, 2024

Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last? - Yahoo Finance

Oct 29, 2024
pulisher
Oct 18, 2024

Zura Bio (NASDAQ:ZURA) versus Omega Therapeutics (NASDAQ:OMGA) Critical Contrast - Defense World

Oct 18, 2024
pulisher
Oct 17, 2024

Omega Therapeutics stock hits 52-week low at $0.94 By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 17, 2024

Cubist Systematic Strategies LLC Grows Holdings in Omega Therapeutics, Inc. (NASDAQ:OMGA) - Defense World

Oct 17, 2024
pulisher
Oct 15, 2024

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

Omega Therapeutics to Present Multiple Posters Highlighting - GlobeNewswire

Oct 15, 2024
pulisher
Oct 09, 2024

Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions - Financial Times

Oct 09, 2024
pulisher
Oct 07, 2024

Omega Therapeutics stock hits 52-week low at $1.07 By Investing.com - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Omega Therapeutics stock hits 52-week low at $1.07 - Investing.com India

Oct 07, 2024
pulisher
Oct 04, 2024

Omega Therapeutics Appoints New Director - Investing.com India

Oct 04, 2024
pulisher
Oct 04, 2024

Omega Therapeutics Welcomes Robert Rosiello to Board - TipRanks

Oct 04, 2024
pulisher
Oct 04, 2024

Omega Therapeutics Appoints New Director By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 03, 2024

Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors – Company Announcement - Financial Times

Oct 03, 2024
pulisher
Oct 03, 2024

Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors - Quantisnow

Oct 03, 2024
pulisher
Oct 02, 2024

A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore - Financial Times

Oct 02, 2024
pulisher
Oct 01, 2024

Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer - Financial Times

Oct 01, 2024
pulisher
Sep 30, 2024

Omega Therapeutics stock hits 52-week low at $1.2 By Investing.com - Investing.com Canada

Sep 30, 2024
pulisher
Sep 30, 2024

Omega Therapeutics stock hits 52-week low at $1.2 - Investing.com

Sep 30, 2024
pulisher
Sep 26, 2024

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry – Company AnnouncementFT.com - Financial Times

Sep 26, 2024
pulisher
Sep 17, 2024

Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications - ForexTV.com

Sep 17, 2024
pulisher
Sep 17, 2024

Omega Therapeutics reports tumor inhibition in liver cancer models - Investing.com

Sep 17, 2024
pulisher
Sep 17, 2024

Omega Therapeutics Announces Publication of Epigenomic - GlobeNewswire

Sep 17, 2024
pulisher
Sep 11, 2024

RNA-Based Therapeutics Market to Grow by USD 1.27 Billion (2024-2028) Due to Increased Investment and Funding, AI Trends Impacting RevenueTechnavio - The Malaysian Reserve

Sep 11, 2024
pulisher
Sep 11, 2024

RNA-Based Therapeutics Market To Grow By USD 1.27 Billion (2024-2028) Due To Increased Investment And Funding, AI Trends Impacting RevenueTechnavio - MENAFN.COM

Sep 11, 2024
pulisher
Sep 10, 2024

Omega Therapeutics (NASDAQ:OMGA) Stock Price Up 0.8% - MarketBeat

Sep 10, 2024
pulisher
Sep 10, 2024

Omega Therapeutics (NASDAQ:OMGA) Shares Up 0.8% - Defense World

Sep 10, 2024
pulisher
Sep 07, 2024

Omega Therapeutics stock hits 52-week low at $1.29 amid downturn - Investing.com Australia

Sep 07, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Capitalizzazione:     |  Volume (24 ore):